Browse > Article
http://dx.doi.org/10.5352/JLS.2018.28.12.1516

Pathophysiological Regulation of Vascular Smooth Muscle Cells by Prostaglandin F2α-dependent Activation of Phospholipase C-β3  

Kang, Ki Ung (Pre-Medical School, Pusan National University School of Medicine)
Oh, Jun Young (Pre-Medical School, Pusan National University School of Medicine)
Lee, Yun Ha (Pre-Medical School, Pusan National University School of Medicine)
Lee, Hye Sun (Gene and Cell Therapy Center for Vessel-Associated Disease, Department of Pharmacology, Pusan National University of School of Medicine)
Jin, Seo Yeon (Gene and Cell Therapy Center for Vessel-Associated Disease, Department of Pharmacology, Pusan National University of School of Medicine)
Bae, Sun Sik (Gene and Cell Therapy Center for Vessel-Associated Disease, Department of Pharmacology, Pusan National University of School of Medicine)
Publication Information
Journal of Life Science / v.28, no.12, 2018 , pp. 1516-1522 More about this Journal
Abstract
Atherosclerosis is an obstructive vessel disease mainly caused by chronic arterial inflammation to which the proliferation and migration of vascular smooth muscle cells (VSMCs) is the main pathological response. In the present study, the primary responsible inflammatory cytokine and its signaling pathway was investigated. The proliferation and migration of VSMCs was significantly enhanced by the prostaglandin $F_{2{\alpha}}$ ($PGF_{2{\alpha}}$), while neither was affected by tumor necrosis factor ${\alpha}$. Prostacyclin $I_2$ was seen to enhance the proliferation of VSMCs while simultaneously suppressing their migration. Both prostaglandin $D_2$ and prostaglandin $E_2$ significantly enhanced the migration of VSMCs, however, proliferation was not affected by either of them. The proliferation and migration of VSMCs stimulated by $PGF_{2{\alpha}}$ progressed in a dose-dependent manner; the $EC_{50}$ value of both proliferation and migration was $0.1{\mu}M$. VSMCs highly expressed the phospholipase isoform $C-{\beta}3$ ($PLC-{\beta}3$) while others such as $PLC-{\beta}1$, $PLC-{\beta}2$, and $PLC-{\beta}4$ were not expressed. Inhibition of the PLCs by U73122 completely blocked the $PGF_{2{\alpha}}$-induced migration of VSMCs, and, in addition, silencing $PLC-{\beta}3$ significantly diminished the $PGF_{2{\alpha}}$-induced proliferation and migration of VSMCs. Given these results, we suggest that $PGF_{2{\alpha}}$ plays a crucial role in the proliferation and migration of VSMCs, and activation of $PLC-{\beta}3$ could be involved in their $PGF_{2{\alpha}}$-dependent migration.
Keywords
Atherosclerosis; migration; proliferation; prostaglandin; VSMC;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Cipollone, F., Prontera, C., Pini, B., Marini, M., Fazia, M., De Cesare, D., Iezzi, A., Ucchino, S., Boccoli, G., Saba, V., Chiarelli, F., Cuccurullo, F. and Mezzetti, A. 2001. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation 104, 921-927.   DOI
2 Gresset, A., Sondek, J. and Harden, T. K. 2012. The phospholipase C isozymes and their regulation. Subcell. Biochem. 58, 61-94.
3 Griffin, B. W., Magnino, P. E., Pang, I. H. and Sharif, N. A. 1998. Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization. J. Pharmacol. Exp. Ther. 286, 411-418.
4 Ha, J. M., Yun, S. J., Kim, Y. W., Jin, S. Y., Lee, H. S., Song, S. H., Shin, H. K. and Bae, S. S. 2015. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1. Biochem. Biophys. Res. Commun. 464, 57-62.   DOI
5 Hohjoh, H., Inazumi, T., Tsuchiya, S. and Sugimoto, Y. 2014. Prostanoid receptors and acute inflammation in skin. Biochimie 107 Pt A, 78-81.   DOI
6 Holvoet, P. 2008. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh. K. Acad. Geneeskd. Belg. 70, 193-219.
7 Kawakami, T. and Xiao, W. 2013. Phospholipase C-beta in immune cells. Adv. Biol. Regul. 53, 249-257.   DOI
8 Kim, D., Jun, K. S., Lee, S. B., Kang, N. G., Min, D. S., Kim, Y. H., Ryu, S. H., Suh, P. G. and Shin, H. S. 1997. Phospholipase C isozymes selectively couple to specific neurotransmitter receptors. Nature 389, 290-293.   DOI
9 Libby, P., Ridker, P. M. and Maseri, A. 2002. Inflammation and atherosclerosis. Circulation 105, 1135-1143.   DOI
10 Kurkowska-Jastrzebska, I., Karlinski, M. A., Blazejewska-Hyzorek, B., Sarzynska-Dlugosz, I., Filipiak, K. J. and Czlonkowska, A. 2016. Carotid intima media thickness and blood biomarkers of atherosclerosis in patients after stroke or myocardial infarction. Croat. Med. J. 57, 548-557.   DOI
11 Oga, T., Matsuoka, T., Yao, C., Nonomura, K., Kitaoka, S., Sakata, D., Kita, Y., Tanizawa, K., Taguchi, Y., Chin, K., Mishima, M., Shimizu, T. and Narumiya, S. 2009. Prostaglandin F(2alpha) receptor signaling facilitates bleomycininduced pulmonary fibrosis independently of transforming growth factor-beta. Nat. Med. 15, 1426-1430.   DOI
12 Pansuria, M., Xi, H., Li, L., Yang, X. F. and Wang, H. 2012. Insulin resistance, metabolic stress, and atherosclerosis. Front. Biosci. (Schol Ed) 4, 916-931.
13 Patrono, C., Garcia Rodriguez, L. A., Landolfi, R. and Baigent, C. 2005. Low-dose aspirin for the prevention of atherothrombosis. N. Engl. J. Med. 353, 2373-2383.   DOI
14 Smith, W. L., Urade, Y. and Jakobsson, P. J. 2011. Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem. Rev. 111, 5821-5865.   DOI
15 Salazar, H. and Archer, D. F. 1974. Ultrastructural changes of the human corpus luteum of pregnancy induced by prostaglandin E2 in vitro. Eur. J. Obstet. Gynecol. Reprod. Biol. 4, S19-33.
16 Santini, G., Mores, N., Malerba, M., Mondino, C., Macis, G. and Montuschi, P. 2016. Investigational prostaglandin D2 receptor antagonists for airway inflammation. Expert. Opin. Investig. Drugs 25, 639-652.   DOI
17 Sasaguri, T. and Miwa, Y. 2004. Prostaglandin J2 family and the cardiovascular system. Curr. Vasc. Pharmacol. 2, 103-114.   DOI
18 Yoshida, T. and Owens, G. K. 2005. Molecular determinants of vascular smooth muscle cell diversity. Circ. Res. 96, 280-291.   DOI
19 Ulven, T. and Kostenis, E. 2006. Targeting the prostaglandin D2 receptors DP and CRTH2 for treatment of inflammation. Curr. Top. Med. Chem. 6, 1427-1444.   DOI
20 Watanabe, T., Nakao, A., Emerling, D., Hashimoto, Y., Tsukamoto, K., Horie, Y., Kinoshita, M. and Kurokawa, K. 1994. Prostaglandin-F2-Alpha enhances tyrosine phosphorylation and DNA-synthesis through phospholipase-C coupled receptor via Ca2+-dependent intracellular pathway in Nih-3t3 cells. J. Biol. Chem. 269, 17619-17625.
21 Blayney, L. M., Gapper, P. W. and Newby, A. C. 1996. Phospholipase C isoforms in vascular smooth muscle and their regulation by G-proteins. Br. J. Pharmacol. 118, 1003-1011.   DOI
22 Ali, M. S., Starke, R. M., Jabbour, P. M., Tjoumakaris, S. I., Gonzalez, L. F., Rosenwasser, R. H., Owens, G. K., Koch, W. J., Greig, N. H. and Dumont, A. S. 2013. TNF-alpha induces phenotypic modulation in cerebral vascular smooth muscle cells: implications for cerebral aneurysm pathology. J. Cereb. Blood Flow Metab. 33, 1564-1573.   DOI
23 Basu, S., Whiteman, M., Mattey, D. L. and Halliwell, B. 2001. Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases. Ann. Rheum. Dis. 60, 627-631.   DOI
24 Bennett, M. R., Sinha, S. and Owens, G. K. 2016. Vascular Smooth Muscle Cells in Atherosclerosis. Circ. Res. 118, 692-702.   DOI
25 Bolognese, R. J. and Corson, S. L. 1975. Interruption of pregnancy by prostaglandin 15-methyl F2alpha. Fertil. Steril. 26, 695-699.   DOI
26 Burleigh, M. E., Babaev, V. R., Yancey, P. G., Major, A. S., McCaleb, J. L., Oates, J. A., Morrow, J. D., Fazio, S. and Linton, M. F. 2005. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice. J. Mol. Cell. Cardiol. 39, 443-452.   DOI
27 Cipollone, F., Cicolini, G. and Bucci, M. 2008. Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives. Pharmacol. Ther. 118, 161-180.   DOI
28 Yu, Y., Lucitt, M. B., Stubbe, J., Cheng, Y., Friis, U. G., Hansen, P. B., Jensen, B. L., Smyth, E. M. and FitzGerald, G. A. 2009. Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis. Proc. Natl. Acad. Sci. USA. 106, 7985-7990.   DOI
29 Yun, S. J., Ha, J. M., Kim, E. K., Kim, Y. W., Jin, S. Y., Lee, D. H., Song, S. H., Kim, C. D., Shin, H. K. and Bae, S. S. 2014. Akt1 isoform modulates phenotypic conversion of vascular smooth muscle cells. Biochim. Biophys. Acta 1842, 2184-2192.   DOI